Reviewer Board
Members of the reviewer board are selected from all Vaccines reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Laboratory of Experimental Nephrology, IDIBELL Hospital Universitari de Bellvitge, L’Hospitalet, E-08907 Barcelona, Spain
Interests: Clinical Nephrology; immunotherapy associated interstitial nephritis; immunecheckpoint inhibitors; autoimmune diseases; renal transplantation; clinical immunosuppression; experimental models; CD40; ctla4; PD1-PDL!/2
Interests: Clinical Nephrology; immunotherapy associated interstitial nephritis; immunecheckpoint inhibitors; autoimmune diseases; renal transplantation; clinical immunosuppression; experimental models; CD40; ctla4; PD1-PDL!/2
1. Departments of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA
2. Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX 77030, USA
3. Cell Biology and Immunology Group, Wageningen University & Research, 6708 WD Wageningen, The Netherlands
Interests: vaccines; mRNA vaccines; CD8+ T cell immunity; parasitology; neglected tropical diseases; kinetoplastids infections; helminth infections
2. Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX 77030, USA
3. Cell Biology and Immunology Group, Wageningen University & Research, 6708 WD Wageningen, The Netherlands
Interests: vaccines; mRNA vaccines; CD8+ T cell immunity; parasitology; neglected tropical diseases; kinetoplastids infections; helminth infections
Department of Hygiene, Microbiology, Social Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria
Interests: HIV; virotherapy; vaccines
Interests: HIV; virotherapy; vaccines
Arthropod-Borne Animal Diseases Research Unit (ABADRU)
U. S. Department of Agriculture (USDA) Agricultural Research Service (ARS)
Interests: Rift Valley fever; Japanese encephalitis virus; arbovirology; vector-host-interations
Interests: Rift Valley fever; Japanese encephalitis virus; arbovirology; vector-host-interations
Biomedical Advanced Research and Development Authority
200 C Street SW
Washington, DC 20024
Interests: immunology; microbiology; virology; vaccine
Interests: immunology; microbiology; virology; vaccine
Department of Biological Sciences, George Washington University, Washington, DC 20052, USA
Interests: hematopoiesis; virology; host-pathogen interaction; myeloid cell development; Immunology
Interests: hematopoiesis; virology; host-pathogen interaction; myeloid cell development; Immunology
School for Engineering of Matter, Transport and Energy, Arizona State University, Tempe, AZ 85287, USA
Interests: Innate immune mechanisms; inflammation; programmed cell death; immune modulation; tissue repair
Interests: Innate immune mechanisms; inflammation; programmed cell death; immune modulation; tissue repair
Department of Pathobiology, University of Illinois at Urbana-Champaign, Rm2627, 2001 S Lincoln Ave., Urbana, IL 61802, USA
Interests: vaccine development; viral diagnostics; mechanism studies or pathogenesis; antibody engineering/therapeutics; emerging viral disease
Interests: vaccine development; viral diagnostics; mechanism studies or pathogenesis; antibody engineering/therapeutics; emerging viral disease
Department of Clinical Science, University of Bergen, Bergen, Norway
Interests: influenza; live attenuated vaccine; humoral immunity; follicular T helper cells; cd4 t cells; children; tonsils
Interests: influenza; live attenuated vaccine; humoral immunity; follicular T helper cells; cd4 t cells; children; tonsils
Department of Structural Chemistry and Biology of Nucleic Acids, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznań, Poland
Interests: influenza virus; hemagglutinin; type II transmembrane serine proteases; proteolytic cleavage; vRNA structure; cell culture-based vaccine production; mirnas; defective interfering particles (DIPs)
Interests: influenza virus; hemagglutinin; type II transmembrane serine proteases; proteolytic cleavage; vRNA structure; cell culture-based vaccine production; mirnas; defective interfering particles (DIPs)
